Back to Trades
Smith Darren Charlton
Group Chief Financial OfficerCIK 0002122447
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 2 filings between 2026, Smith Darren Charlton, Group Chief Financial Officer, has disclosed $0 in transactions — all concentrated in Telix Pharmaceuticals Ltd (TLX). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Apr 1 | TLX Telix Pharmaceuticals Ltd | Smith Darren Charlton | Group Chief Financial Officer | Exercise | $0 |
| Apr 1 | TLX Telix Pharmaceuticals Ltd | Smith Darren Charlton | Group Chief Financial Officer | Other | $0 |
2 filings